Serum apelin-13 levels and total oxidant/antioxidant status of patients with Alzheimer's disease.
Zeynep YildizNezaket ErenAsuman OrcunFatma Münevver GokyigitFatma TurgayLale Gündogdu CelebiPublished in: Aging medicine (Milton (N.S.W)) (2021)
According to our results, we suggested that insufficient apelin-13 and TAS levels may contribute to the pathogenesis of AD.